author['full_name']

After pushback, J&J authorizes generics of its tuberculosis drug

Following a campaign of public pressure, Johnson & Johnson (J&J) will allow a Swiss non-profit organization to supply generic bedaquiline (Sirturo) to low- and middle-income countries for the treatment of multidrug-resistant tuberculosis (TB). The campaign accused the global pharmaceutical maker of playing patent games to prevent wider distribution of the drug in low-income countries. The …

After pushback, J&J authorizes generics of its tuberculosis drug Read More »